Related Experiment Video
Updated: May 25, 2026
07:46
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
1Department of Cardiology, University of Heidelberg Heidelberg, Germany.
Frontiers in Physiology
|January 26, 2012
Summary
Platelet chemokine CXCL4 induces distinct macrophages, termed "M4," which differ from M-CSF-induced macrophages and exhibit impaired hemoglobin clearance, potentially impacting atherosclerosis progression.
Area of Science:
- Cardiovascular Biology
- Immunology
- Cell Biology
Background:
- Monocytes differentiate into macrophages and foam cells during atherogenesis.
- Macrophage colony-stimulating factor (M-CSF) is a key driver of monocyte-macrophage differentiation.
- Platelet chemokine CXCL4 also promotes monocyte differentiation and survival in vitro.
Purpose of the Study:
- To investigate the characteristics of human macrophages differentiated by CXCL4.
- To compare CXCL4-induced macrophages with M-CSF-induced and other polarized macrophage types.
- To explore the role of CXCL4-induced macrophages in atherogenesis.
Main Methods:
- Gene chip analysis
- Systems biology approaches
- In vitro and ex vivo functional experiments
Main Results:
- CXCL4-induced macrophages exhibit distinct phenotypes and functions compared to M-CSF-induced, M1, or M2 macrophages.
- CXCL4-induced macrophages lack the CD163 scavenger receptor, impairing hemoglobin clearance.
- These macrophages cannot upregulate heme oxygenase-1 in response to hemoglobin-haptoglobin complexes.
Conclusions:
- CXCL4 induces a unique macrophage subset, proposed as "M4" macrophages.
- CXCL4-induced "M4" macrophages may contribute to atherogenesis through altered functional properties.
- CXCL4 orchestrates macrophage heterogeneity in atherosclerotic lesions, offering potential therapeutic targets.
Related Concept Videos
01:38Inflammation
Overview
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...